The generic drug market in the United States is characterized by significant price volatility and shortages, driven by the structure […]
How to Develop a Competitive Generic Drug Portfolio Read Post »
Navigating the complex landscape of biotech funding can be daunting, especially for startups that require substantial capital to support their
How to Identify the Best Biotech Funding Opportunities Read Post »
The biopharmaceutical industry is constantly evolving, with the demand for complex biologics on the rise. To stay competitive, companies must […]
Cutting Costs with a CDMO: Strategies for Success in Biopharmaceutical Manufacturing Read Post »
AMITIZA (lubiprostone) Sucampo pharma llc Patent: 7,795,312 Expiration: Sep 17, 2024 See More … For more information on how DrugPatentWatch […]
Drug Patent Expirations for the Week of September 15, 2024 Read Post »
Introduction Biosimilars, which are highly similar versions of biologic drugs, have the potential to significantly reduce healthcare costs by offering
Enhancing Your Product Portfolio with CDMOs: A Strategic Partnership for Pharmaceutical Success The pharmaceutical industry is constantly evolving, driven by […]
In the high-stakes world of pharmaceuticals, where innovation meets profit, a little-known regulatory program called REMS (Risk Evaluation and Mitigation […]
REMS: The Regulatory Shield Blocking Affordable Generics Read Post »
Introduction Navigating the biotech funding ecosystem can be a daunting task for startups. The biotech industry is characterized by high
Introduction Biotech companies face unique financial challenges due to the lengthy and costly process of developing and commercializing biotech products.
The Role of Strategic Planning in Biotech Financing Read Post »
In the labyrinthine world of pharmaceuticals, where the cost of life-saving medications can often feel like a roll of the […]
The ‘Rule of Three’: How the FDA is Hacking Drug Prices Read Post »
Get new actionable insights and updates from BiotechBlog
